298 related articles for article (PubMed ID: 37695391)
1. LncRNA MALAT1 signaling pathway and clinical applications in overcome on cancers metastasis.
Mazarei M; Shahabi Rabori V; Ghasemi N; Salehi M; Rayatpisheh N; Jahangiri N; Saberiyan M
Clin Exp Med; 2023 Dec; 23(8):4457-4472. PubMed ID: 37695391
[TBL] [Abstract][Full Text] [Related]
2. Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.
Farzaneh M; Najafi S; Dari MAG; Sheykhi-Sabzehpoush M; Dayer D; Cheraghzadeh M; Azizidoost S
Clin Transl Oncol; 2023 Jan; 25(1):48-65. PubMed ID: 36042115
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Long Noncoding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis by Targeting miR-124 in Retinoblastoma.
Liu S; Yan G; Zhang J; Yu L
Oncol Res; 2018 May; 26(4):581-591. PubMed ID: 28550678
[TBL] [Abstract][Full Text] [Related]
5. Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance.
Hashemi M; Hasani S; Hajimazdarany S; Mirmazloomi SR; Makvandy S; Zabihi A; Goldoost Y; Gholinia N; Kakavand A; Tavakolpournegari A; Salimimoghadam S; Nabavi N; Zarrabi A; Taheriazam A; Entezari M; Hushmandi K
Int J Biol Macromol; 2022 Dec; 222(Pt A):1151-1167. PubMed ID: 36191781
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MALAT1-related signaling pathways in osteosarcoma.
Farzaneh M; Najafi S; Anbiyaee O; Azizidoost S; Khoshnam SE
Clin Transl Oncol; 2023 Jan; 25(1):21-32. PubMed ID: 35790599
[TBL] [Abstract][Full Text] [Related]
7. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
Yang G; Zhang C; Wang N; Chen J
Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
[TBL] [Abstract][Full Text] [Related]
8. Multiple function of lncRNA MALAT1 in cancer occurrence and progression.
Malakoti F; Targhazeh N; Karimzadeh H; Mohammadi E; Asadi M; Asemi Z; Alemi F
Chem Biol Drug Des; 2023 May; 101(5):1113-1137. PubMed ID: 34918470
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanism of the Canonical Oncogenic lncRNA MALAT1 in Gastric Cancer.
Xu W; Ding M; Wang B; Cai Y; Guo C; Yuan C
Curr Med Chem; 2021; 28(42):8800-8809. PubMed ID: 34036905
[TBL] [Abstract][Full Text] [Related]
10. MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting.
Bhat AA; Afzal O; Afzal M; Gupta G; Thapa R; Ali H; Hassan Almalki W; Kazmi I; Alzarea SI; Saleem S; Samuel VP; Gubbiyappa SK; Subramaniyan V
Pathol Res Pract; 2024 Jan; 253():154991. PubMed ID: 38070223
[TBL] [Abstract][Full Text] [Related]
11. ARID3A and ARID3B exert direct regulatory control over the long non-coding RNAs (lncRNAs) MALAT1 and NORAD within the context of non-small cell lung cancer (NSCLC).
Nasuh S; Balci SO; Bozgeyik I; Ikeda MA; Tekayev M; Saadat KASM
Pathol Res Pract; 2023 Dec; 252():154948. PubMed ID: 37977034
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
Zuo Y; Li Y; Zhou Z; Ma M; Fu K
Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma.
Chang HL; Bamodu OA; Ong JR; Lee WH; Yeh CT; Tsai JT
Cells; 2020 Apr; 9(4):. PubMed ID: 32326045
[TBL] [Abstract][Full Text] [Related]
16. MALAT1 modulates the autophagy of retinoblastoma cell through miR-124-mediated stx17 regulation.
Huang J; Yang Y; Fang F; Liu K
J Cell Biochem; 2018 May; 119(5):3853-3863. PubMed ID: 29073720
[TBL] [Abstract][Full Text] [Related]
17. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
Shi B; Wang Y; Yin F
Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
Liu X; Zhao W; Wang X
Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
[TBL] [Abstract][Full Text] [Related]
19. MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.
Matuszyk J
Mol Med; 2022 Aug; 28(1):89. PubMed ID: 35922756
[TBL] [Abstract][Full Text] [Related]
20. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
Wang Z; Chang X; Zhu G; Gao X; Chang L
Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
